Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03508986

Chinese FPD Registry

The purpose of the Chinese Familial Parkinson's disease Registry (CFPDR) is to develop a database of patients with familial Parkinson's disease (PD) in China.

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

Parkinson's disease (PD) is the second most common disorder among degenerative neurological disease. Familial PD (FPD) has its unique clinical feature and genetic basis. We aim to establish a database of FPD,and characterize the clinical feature, genetic basis, environmental factors and their interactions FPD in China.

Method:

  • Clinical feature will be measured by scales and neurological tests.Standard scales includes: Unified Parkinson's Disease Rating Scale(UPDRS), Hoehn-Yahr stages, NMSS, MMSE, PDSS(Parkinson disease sleep scales),Rapid Eye Movement Sleep Behaviour Disorder Questionnaire(RBDQ-HK),ESS(Epworth Sleepiness Scale),Rome III functional constipation scale,SCOPA-AUT (the Scale for Outcomes in PD for Autonomic Symptoms),PFS(Parkinson Fatigue Scale),CH-RLSq,Hyposmia rating scale(HRS)HAMILT depression scale,the 39-item Parkinson's Disease Questionnaire(PDQ-39),Freezing of gait scale(FOG),dyskinesia related scales, Wearing-off scale(WO)
  • Peripheral blood from patients and other members in family will be collected for familial PD genetic testing.
  • The environmental factors are exploded by questionnaires including smoking,drinking, pesticide and heavy metals.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of Parkinson's disease, and either family history of Parkinson's disease (first or second degree family member affected by Parkinson's disease) AND/OR Clinical diagnosis of Parkinson's disease and their parents are close relatives(First or second degree family member of an Index Case, affected or unaffected by Parkinson's disease).

Exclusion criteria

  • Lack of capacity to consent to participate in the project

Treatment and study plan

Primary outcomes

  1. Database of Familial Parkinson's disease

    Time frame: 10 years

    To collect 1500 patients with familial Parkinson's disease and establish the database of Familial Parkinson's disease (FPD) in mainland China.

  2. Risk Factors

    Time frame: 10 years

    To characterize clinical feature and environmental factors among Chinese familial parkinson's disease

  3. Genetic Basis

    Time frame: 10 years

    To characterize the genetic basis of Chinese FPD and detect clinically relevant genetic variants in these cases

Study contacts

Contact information is provided by the study sponsor or research team.

Beisha Tang, Ph.D.

CONTACT

[email protected]

+8613974856709

Jifeng Guo, Ph.D.

CONTACT

[email protected]

+8613974936815

Sponsors and collaborators

Lead sponsor

Xiangya Hospital of Central South University

Other

Registry information

Official study title

The Chinese Familial Parkinson's Disease Registry

Important dates

Study start
2017
Primary completion
2027
Study completion
2027
First posted
Apr 26, 2018
Registry last updated
May 11, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.